What is PT Siloam International Hospitals Tbk EBITDA Margin %?
PT Siloam International Hospitals TbkFRA:2LS -3.02%91 EBITDA Margin % is 20.97% as of Mar. 2026, which is 36% above its 10-year median of 15.43. GuruFocus rates FRA:2LS with a GF Score™ of 91/100 and a GF Value™ of €0.13 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, PT Siloam International Hospitals Tbk ranks better than 77.69% on this metric.
PT Siloam International Hospitals Tbk (FRA:2LS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
PT Siloam International Hospitals Tbk EBITDA Margin % Related Terms
PT Siloam International Hospitals Tbk EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk EBITDA Margin % Chart
FRA:2LS vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Siloam International Hospitals Tbk EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where PT Siloam International Hospitals Tbk's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk (FRA:2LS) has a EBITDA Margin % of 20.97% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Siloam International Hospitals Tbk and its competitors. This is 36% above median its historical median of 15.43. Over the past decade, PT Siloam International Hospitals Tbk's EBITDA Margin % has ranged from 2.15 to 22.60. According to the industry distribution chart, PT Siloam International Hospitals Tbk ranks #149 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 22.3%.
Is PT Siloam International Hospitals Tbk's EBITDA Margin % too high?
PT Siloam International Hospitals Tbk's current EBITDA Margin % of 20.97% is 36% above median its 10-year median of 15.43. Over the past 10 years, this metric has ranged from a low of 2.15 to a high of 22.60. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. PT Siloam International Hospitals Tbk's value of 20.97% is 105.4% above this industry median. Based on the distribution chart, PT Siloam International Hospitals Tbk ranks #149 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Siloam International Hospitals Tbk ranks #149 out of 668 companies for EBITDA Margin %. This places PT Siloam International Hospitals Tbk in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. PT Siloam International Hospitals Tbk's value of 20.97% is 105.4% above this benchmark. Historically, PT Siloam International Hospitals Tbk's own EBITDA Margin % has ranged from 2.15 to 22.60 over the past decade. While the company's 10-year median is 15.43 vs. the industry median of 10.21, PT Siloam International Hospitals Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Siloam International Hospitals Tbk's current EBITDA Margin % of 20.97% is 105.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Siloam International Hospitals Tbk and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Siloam International Hospitals Tbk's current EBITDA Margin % is 20.97%, which is 36% above median its own 10-year median of 15.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk (FRA:2LS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.13, compared to a current price of €0.10 — trading 25.8% below its estimated fair value. The current EBITDA Margin % is 20.97%, which is 36% above median its 10-year median of 15.43 and 105.4% above the Healthcare Providers & Services industry median of 10.21. PT Siloam International Hospitals Tbk's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current EBITDA Margin % is 20.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued.
The current stock price of €0.10 is trading 25.8% below its estimated GF Value™ of €0.13.
GuruFocus considers PT Siloam International Hospitals Tbk to be Modestly Undervalued.
Key valuation signals for FRA:2LS:
EBITDA Margin %: 20.97% (36% above median its 10-year median of 15.43)
GF Value™: €0.13 vs. price of €0.10 (25.8% below fair value)
Industry Position: 105.4% above the Healthcare Providers & Services median (#149 of 668)
No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Siloam International Hospitals Tbk Business Description
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
91GF Score
Get the complete analysis for FRA:2LS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2LS has been successfully added to your 
